All articles tagged with #recurrence prevention
Researchers at Penn Medicine have developed a test to detect and eliminate dormant breast cancer cells, potentially preventing cancer recurrence. The strategy involves using existing drugs to target these 'sleeper' cells before they become active, with ongoing clinical trials showing promising results, including reduced relapse rates and decreased patient anxiety.
A study published in the New England Journal of Medicine found that regular exercise, such as brisk walking four times a week, can significantly reduce the risk of colon cancer recurrence by 28% and improve five-year disease-free survival rates, highlighting the importance of lifestyle factors in cancer prevention and management.
Jennifer Davis, a breast cancer survivor, became the first person to receive a breast cancer vaccine in a trial study at Cleveland Clinic in 2021. The vaccine has been in development for over 20 years and is licensed to Anixa Biosciences. The vaccine is currently being tested on 14 patients, and the results are expected to be presented at the annual meeting of the American Association of Cancer Research. If successful, the vaccine could be available for recurrence prevention within four to five years and for primary prevention a few years after that.
Jennifer Davis, a breast cancer survivor, was the first person to receive a breast cancer vaccine in a clinical trial at Cleveland Clinic. The vaccine has been in development for over 20 years and is licensed to Anixa Biosciences. The vaccine is currently being tested on 14 patients, and the results will be presented at the annual meeting of the American Association of Cancer Research. If successful, the vaccine could be available for recurrence prevention within four to five years and for primary prevention a few years after that.